JPMorgan Chase & Co.'s Chief Executive Jamie Dimon told analysts on Wednesday he plans to stay in the job "for a few more ...
GlobalData on MSN7h
JP Morgan 2025: GoodRx takes aim at US drug pricing challengesGoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.
JPMorgan Chase posted strong Q4 results, with EPS up 58% y/y and IB revenues up 46% y/y, beating analyst estimates. Learn ...
The bank – the largest in the US with more than 300,000 employees worldwide – is expected to announce the change in the next ...
One of the leading contenders to become CEO of JPMorgan Chase , Jennifer Piepszak, on Tuesday took herself out of the running ...
GlobalData on MSN19h
JP Morgan 2025: AbbVie counts on Skyrizi and Rinvoq to fill Humira-sized holeAbbVie executives said they have high hopes for Skyrizi and Rinvoq in the inflammatory bowel disease market after Humira ...
JPMorgan Chase management disabled comments on an internal webpage where the policy was announced, according to the Wall ...
Analysts have been eager to weigh in on the Financial sector with new ratings on JPMorgan Chase & Co. (JPM – Research Report), Bank of New ...
GlobalData on MSN1d
JP Morgan 2025: Novartis streamlines its portfolio to drive future growthEight blockbuster drugs are expected to generate over $3bn in peak sales each according to Novartis CEO Vas Narasimhan.
The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback